Inovio Pharmaceuticals (INO) Exchange Rate Effect (2010 - 2024)
Inovio Pharmaceuticals' (INO) quarterly Exchange Rate Effect came in at $32403.0 in Q1 2024, up 1789.42% year-over-year from $1715.0 in Q2 2023, and up 6608.7% quarter-over-quarter from $483.0 in Q4 2023.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Exchange Rate Effect (2010 - 2024) Analysis & Trends
Inovio Pharmaceuticals has disclosed Exchange Rate Effect across 10 years of filings, most recently posting $32403.0 for Q1 2024.
- In Q1 2024, Exchange Rate Effect rose 1789.42% year-over-year to $32403.0; the TTM figure through Dec 2024 stood at $32403.0 (up 926.61% YoY), while the FY2024 annual figure was $32403.0, up 926.61% from the prior year.
- Exchange Rate Effect came in at $32403.0 for Q1 2024 at Inovio Pharmaceuticals, up from $483.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $32403.0 in Q1 2024 to a low of -$16563.0 in Q3 2022.
- Average Exchange Rate Effect over 5 years is -$0.13, with a median of -$1918.0 recorded in 2023.
- Year-over-year, Exchange Rate Effect plunged 696.65% in 2022 and soared 1789.42% in 2024.
- Over 5 years, Exchange Rate Effect stood at $21021.0 in 2020, then plunged by 134.83% to -$7321.0 in 2021, then soared by 268.65% to $12347.0 in 2022, then sank by 96.09% to $483.0 in 2023, then surged by 6608.7% to $32403.0 in 2024.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $32403.0 in Q1 2024, $483.0 in Q4 2023, and -$2109.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Inovio Pharmaceuticals | 104.88 Mn | 104.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 32,403.00 |
| Dec 31, 2023 | 483.00 |
| Sep 30, 2023 | -2,109.00 |
| Jun 30, 2023 | -376.00 |
| Mar 31, 2023 | -1,918.00 |
| Dec 31, 2022 | 12,347.00 |
| Sep 30, 2022 | -16,563.00 |
| Jun 30, 2022 | -14,785.00 |
| Mar 31, 2022 | -6,555.00 |
| Dec 31, 2021 | -7,321.00 |
| Sep 30, 2021 | -10,872.00 |
| Jun 30, 2021 | 2,478.00 |
| Mar 31, 2021 | -14,419.00 |
| Dec 31, 2020 | 21,021.00 |
| Sep 30, 2020 | 6,184.00 |
| Mar 31, 2014 | -1,689.00 |
| Dec 31, 2013 | 462.00 |
| Sep 30, 2013 | 1,331.00 |
| Jun 30, 2013 | -486.00 |
| Mar 31, 2013 | -1,189.00 |